Scientists study 'super-agers' and rare ApoE gene variants to find Alzheimer's clues
Geneticist Henne Holstege began a 2013 project studying people who remain resistant to dementia despite age or genetic risk factors, after years of failed funding attempts. Researchers have since identified several rare gene variants, including some affecting the ApoE protein, that appear to protect the brain against the toxic proteins linked to Alzheimer's disease.
GoKawiil's interpretation of the reporting above, not reported fact.
Studying natural resistance rather than just risk could reveal previously unknown biological defence mechanisms in the brain, according to researchers in the field. Neuroscientist Guojun Bu suggests that understanding how these protective variants work safely could point toward new therapeutic approaches for Alzheimer's, though no treatments have yet emerged from this research.
- Holstege's 'super-ager' research project launched in 2013 after five years of rejected funding applications.
- Rare genetic variants, some affecting the ApoE protein, appear to protect certain people from Alzheimer's despite risk factors.
- Researchers hope studying these protective mechanisms could eventually guide development of new Alzheimer's therapies.
Source: nature.com — Abbott, 2026-11-10
Published there as: “Some people are resistant to dementia — here’s what their genes can teach us”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.